Xiaojun Xu

1.7k total citations · 1 hit paper
65 papers, 1.1k citations indexed

About

Xiaojun Xu is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Xiaojun Xu has authored 65 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 28 papers in Molecular Biology and 15 papers in Immunology. Recurrent topics in Xiaojun Xu's work include Acute Myeloid Leukemia Research (18 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Immune Cell Function and Interaction (7 papers). Xiaojun Xu is often cited by papers focused on Acute Myeloid Leukemia Research (18 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Immune Cell Function and Interaction (7 papers). Xiaojun Xu collaborates with scholars based in China, United States and Hong Kong. Xiaojun Xu's co-authors include Qifa Liu, Kui Song, Li Xuan, Yan Pang, Ping Han, Xianqun Fan, Colin Story, Greg Hodge, Bo Lü and Ruhe Zhang and has published in prestigious journals such as Blood, ACS Nano and PLoS ONE.

In The Last Decade

Xiaojun Xu

58 papers receiving 1.1k citations

Hit Papers

Mitochondria in oxidative... 2025 2026 2025 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaojun Xu China 18 416 312 189 153 132 65 1.1k
Dongjun Lin China 17 302 0.7× 198 0.6× 91 0.5× 123 0.8× 59 0.4× 63 819
Zeng Fan China 17 609 1.5× 103 0.3× 125 0.7× 278 1.8× 191 1.4× 62 1.2k
Yulai Zhou China 24 759 1.8× 122 0.4× 207 1.1× 204 1.3× 220 1.7× 69 1.5k
Yan Xiong China 24 869 2.1× 129 0.4× 146 0.8× 291 1.9× 272 2.1× 122 1.8k
Ian M. Rogers Canada 22 780 1.9× 165 0.5× 128 0.7× 127 0.8× 117 0.9× 60 1.7k
Zhu Chen China 19 515 1.2× 121 0.4× 408 2.2× 215 1.4× 135 1.0× 44 1.4k
Mehdi Talebi Iran 23 736 1.8× 93 0.3× 216 1.1× 179 1.2× 296 2.2× 63 1.4k
Carine Fillebeen Canada 22 548 1.3× 512 1.6× 76 0.4× 71 0.5× 97 0.7× 43 1.5k
Rita Cascão Portugal 16 425 1.0× 129 0.4× 279 1.5× 127 0.8× 78 0.6× 39 1.1k
Ezzatollah Fathi Iran 29 709 1.7× 186 0.6× 192 1.0× 202 1.3× 261 2.0× 86 1.7k

Countries citing papers authored by Xiaojun Xu

Since Specialization
Citations

This map shows the geographic impact of Xiaojun Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojun Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojun Xu more than expected).

Fields of papers citing papers by Xiaojun Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojun Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojun Xu. The network helps show where Xiaojun Xu may publish in the future.

Co-authorship network of co-authors of Xiaojun Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojun Xu. A scholar is included among the top collaborators of Xiaojun Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojun Xu. Xiaojun Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xiaohe, et al.. (2025). Multifunctional GelMA hydrogel doped with spermidine-ferrocene polymeric nanoparticles for accelerative diabetic wound healing. Chinese Chemical Letters. 36(11). 110848–110848. 5 indexed citations
2.
Xu, Xiaojun, Guozhen Shen, Zhidong Liu, et al.. (2025). Targeting macrophage polarization by inhibiting Pim2 alleviates inflammatory arthritis via metabolic reprogramming. Cellular and Molecular Immunology. 22(4). 418–436. 11 indexed citations
4.
Tang, Jing, et al.. (2024). Construction of AML prognostic model with CYP2E1 and GALNT12 biomarkers based on golgi- associated genes. Annals of Hematology. 103(12). 5297–5314. 13 indexed citations
5.
Liu, Yu, Yunsheng Xu, Xiaobo Wang, et al.. (2023). Elastin-Derived VGVAPG Fragment Decorated Cell-Penetrating Peptide with Improved Gene Delivery Efficacy. Pharmaceutics. 15(2). 670–670. 5 indexed citations
6.
Nie, Tianqi, Hengyu Liu, Ruhe Zhang, et al.. (2023). Tumor Microenvironment Mediated Spermidine-Metal-Immunopeptide Nanocomplex for Boosting Ferroptotic Immunotherapy of Lymphoma. ACS Nano. 17(11). 10925–10937. 43 indexed citations
7.
Pei, Han Zhong, Xiaomei Zhuang, Xiaobo Wang, et al.. (2023). miR-221/222 induce instability of p53 By downregulating deubiquitinase YOD1 in acute myeloid leukemia. Cell Death Discovery. 9(1). 249–249. 7 indexed citations
8.
Su, Zepeng, Jinteng Li, Jiajie Lin, et al.. (2023). TNF‐α‐Induced KAT2A Impedes BMMSC Quiescence by Mediating Succinylation of the Mitophagy‐Related Protein VCP. Advanced Science. 11(10). e2303388–e2303388. 10 indexed citations
9.
Wang, Xiaobo, et al.. (2023). Glutathione promotes the synergistic effects of venetoclax and azacytidine against myelodysplastic syndrome‑refractory anemia by regulating the cell cycle. Experimental and Therapeutic Medicine. 26(6). 574–574. 2 indexed citations
10.
Lü, Bo, Yuming Zhao, Junbin Huang, et al.. (2022). Aberrantly expressed Wnt5a in nurse-like cells drives resistance to Venetoclax in chronic lymphocytic leukemia. Cell Death Discovery. 8(1). 82–82. 15 indexed citations
11.
Wang, Xiaobo, et al.. (2022). UNC13B Promote Arsenic Trioxide Resistance in Chronic Lymphoid Leukemia Through Mitochondria Quality Control. Frontiers in Oncology. 12. 920999–920999. 3 indexed citations
12.
Zhao, Yuming, et al.. (2021). Tyrosine Kinase ROR1 as a Target for Anti-Cancer Therapies. Frontiers in Oncology. 11. 680834–680834. 67 indexed citations
13.
Zhao, Yuming, Zhiguang Chang, Junbin Huang, et al.. (2021). Expression of a recombinant FLT3 ligand and its emtansine conjugate as a therapeutic candidate against acute myeloid leukemia cells with FLT3 expression. Microbial Cell Factories. 20(1). 67–67. 6 indexed citations
15.
Wang, Xiaobo, Leping Yan, Lihua Yuan, et al.. (2019). CIAPIN1 is a potential target for apoptosis of multiple myeloma. Materials Express. 9(9). 1106–1111.
16.
Xu, Xiaojun, Mingwan Zhang, Xiaochun Bai, et al.. (2015). Low-dose arsenic trioxide combined with aclacinomycin A synergistically enhances the cytotoxic effect on human acute myelogenous leukemia cell lines by induction of apoptosis. Leukemia & lymphoma. 56(11). 3159–3167. 5 indexed citations
20.
Sjölund, Karl‐Fredrik, et al.. (1998). Intrathecal administration of the adenosine A1 receptor agonist R-phenylisopropyl adenosine reduces presumed pain behaviour in a rat model of central pain. Neuroscience Letters. 243(1-3). 89–92. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026